In this complex and fast-changing environment, timely, data-driven portfolio planning decisions are necessary. Our industry experts, data scientists and epidemiologists help pharma teams make sense of the vast amount of available epidemiological, real-world patient and market data to understand the global and localized markets, from a high-level overview to the most granular niche patient segments. Identify the treatment that will have the greatest impact for patients, whether it’s a broad application or within a personalized medicine approach.
With access to insights on M&A activity, challenging pricing and purchasing conditions, drug pipeline and customer dynamics, our experts help you understand the disease population and competitive landscape of interest for more accurate forecasting and greater confidence in planning commercial investments.
“Through Cortellis Competitive Intelligence, we have the most reliable and updated source of drug intelligence to drive our Marketing and Business Development strategic choices.”
“We really needed a fast way to find out who is developing a similar drug. We couldn’t easily identify where there may be competitive threats or opportunities to collaborate. Now, Cortellis gives us that functionality.”
“We can now trace the development of industry trends and learn about changes in various ingredients or preparations first. It’s an essential strategic tool when making important decisions. We’re no longer looking for additional analysis or monitoring tools because [the Clarivate products] meet all our business needs.”
“My favorite part of the day is getting into the office and opening up BioWorld. It’s the very first thing I do. It’s a good representation across the industry of the most relevant topics from finance to clinical development – not only in the U.S., but international.”
“Before switching to Cortellis Deals Intelligence [CDI], searching through the publicly available data for deal comps, valuations and other deal information was an effort that took up way too much of my time. CDI is an essential tool to have as it allows me to get quickly to the deal information I need.” Chief Business Officer, Biotechnology Company
Always have a fresh, comprehensive and accurate view of your key markets
Evaluate market opportunities and investments with increased accuracy and confidence
Identify opportunities to influence treatment choice and drive positive health outcomes
Full spectrum of intelligence solutions for the drug lifecycle:
Our Research Intelligence Cloud makes it easier for you to collect, analyze and gain precise, actionable insights across the entire R&D lifecycle, meaning you can make critical decisions faster and with greater confidence.